OxyContin, OxyNEO $20M class action settlement

Update:

• The claim deadline has been extended to June 27, 2024.
• Claimants who received a deficiency notice dated Oct. 13, 2023, will have until June 27, 2024, to cure their claims.

Purdue Pharma agreed to pay $20 million as part of a settlement to resolve claims it negligently released OxyContin in Canadian markets, resulting in overdoses and addiction. 

The settlement benefits Canadians who were prescribed and ingested OxyContin and/or OxyNEO between Jan. 1, 1996, and Feb. 28, 2017, or their surviving family members. 

According to several class action lawsuits against Purdue, the pharmaceutical company failed to disclose the addictive nature of its OxyContin and OxyNEO products. As a result, Canadians allegedly became addicted to the opioid medications and, in some cases, experienced deadly overdoses.

Purdue Pharma is a pharmaceutical manufacturer that sells products such as opioids, opioid overdose reversal drugs and more.

Purdue hasn’t admitted any wrongdoing but agreed to a $20 million settlement to resolve the OxyContin class action lawsuits.

Under the terms of the settlement, class members can receive a cash payment based on their experience with OxyContin and OxyNEO, including any prescription details, addiction and other damages resulting from the medications. 

Family members who can prove a relation to an affected individual may also be eligible for payments. Exact payments amount will vary depending on the number of valid claims filed and the “points” assigned to each case.

There is no objection or exclusion deadline listed on the settlement website. 

A judge granted the OxyContin settlement final approval Feb. 6, 2023.

In order to receive settlement benefits, class members must submit a valid claim form by the extended deadline of June 27, 2024.

Who’s Eligible

Canadians who were prescribed and ingested OxyContin and/or OxyNEO between Jan. 1, 1996, and Feb. 28, 2017, or their surviving family members.

Potential Award

Varies

Proof of Purchase

Proof of valid prescriptions, proof of addiction and other medical records.

Claim Form

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.

Claim Form Deadline

06/27/2024

Case Name

Mackay, et al. v. Purdue Pharma Inc., et al., Case No. 07-CV-343201CP, in the Ontario Superior Court of Justice

Bellefontaine, et al. v. Purdue Frederick Inc., et al., Case No. 285995, in the Supreme Court of Nova Scotia

Larose, et al. v. Purdue Pharma Inc., et al., Case No. 200-60-000080-070, in the Superior Court of Quebec

Miller, et al. v. Purdue Pharma, et al., Case No. 1073/2012, in the Queen’s Bench Judicial Centre of Regina, Saskatchewan

Newton v. Purdue Pharma, et al., Case No. 07586, in the Supreme Court of British Columbia

Melanson v. Purdue Frederick Inc., et al., Case No. W/C/44/09, in the Court of Queen’s Bench of New Brunswick

Critchley v. Purdue Frederick, et al., Case No. 2009-01T-2102-CP, in the Supreme Court of Newfoundland and Labrador

Stewart v. Purdue Frederick, et al., Case No. S1-GS-23185, in the Supreme Court of Prince Edward Island

Juchacz v. Purdue Pharma, et al., Case No. 1163 of 2008, in the Queen’s Bench Judicial Centre of Regina, Saskatchewan

Black v. Purdue Pharma, et al., Case No. 0801-08779, in the Court of Queen’s Bench of Alberta

Final Hearing

11/08/2022

Settlement Website

OxyContinClassActionSettlement.ca

Claims Administrator

RicePoint Administration Inc.
P.O. Box 3355
London (Ontario)
N6A 4K3
oxycontin@ricepoint.com
888-663-7185

Class Counsel

ROCHON GENOVA LLP

SISKINDS LLP

WAGNERS AND MERCHANT LAW GROUP LLP

Defense Counsel

BORDEN LADNER GERVAIS LLP

STIKEMAN ELLIOT LLP

BARRY GLASPELL BARRISTER AND SOLICITOR